Updated KDIGO Guidelines for Chronic Kidney Disease

This update focuses on routine use of cystatin C for estimating kidney function and SGLT-2 inhibitors and statins for improving outcomes.

Sponsoring Organization: Kidney Disease: Improving Global Outcomes (KDIGO)

Background

KDIGO has published updated guidelines for evaluation, risk assessment, and management of patients with chronic kidney disease (CKD) who are not yet receiving renal replacement therapy (RRT; i.e., dialysis or transplantation). The KDIGO working group has included 28 recommendations (based on research evidence) and >100 practice points (based on consensus expert opinion) in their document; however, this summary focuses on key advice that should influence clinical practice for those caring for patients with or at risk for CKD.

Key Recommendations

(1) Evaluation of CKD

Estimate glomerular filtration rate (GFR): Use the average of creatinine-based GFR estimation an…

Reviewing Author

Daniel D. Dressler, MD, MSc, MHM, FACP

Disclosures

RoyaltiesMcGraw-Hill; Elsevier

Editorial BoardsMedical Clinics of North America; Caribbean Medical Journal International Advisory Panel (2021–2026)